OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
Juan Ramón Perea, Marta Bolós, Raquel Cuadros, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1632-1648
Open Access | Times Cited: 15

Showing 15 citing articles:

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Eunshil Lee, Yongmin Chang
Cells (2025) Vol. 14, Iss. 3, pp. 168-168
Open Access | Times Cited: 1

The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer’s Disease
Zhiwei Shen, Xinyi Yang, Yu‐Long Lan, et al.
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 3, pp. 741-754
Closed Access | Times Cited: 5

Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
Elisa Medrano-Jiménez, Karla F. Meza‐Sosa, José A Urbán-Aragón, et al.
Journal of Leukocyte Biology (2022) Vol. 112, Iss. 1, pp. 47-77
Closed Access | Times Cited: 20

Dysfunctional microglia and tau pathology in Alzheimer’s disease
Gunel Ayyubova
Reviews in the Neurosciences (2022) Vol. 34, Iss. 4, pp. 443-458
Closed Access | Times Cited: 20

Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties
Vinayak Nayak, Sushmita Patra, Shrushti Rout, et al.
Phytomedicine (2023) Vol. 122, pp. 155150-155150
Closed Access | Times Cited: 8

Roles in Innate Immunity
Kaira A. Church, Astrid E. Cardona, Sarah C. Hopp
Advances in neurobiology (2024), pp. 263-286
Closed Access | Times Cited: 2

p38α Mitogen-Activated Protein Kinase—An Emerging Drug Target for the Treatment of Alzheimer’s Disease
Jan Detka, Natalia Płachtij, Martyna Strzelec, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4354-4354
Open Access | Times Cited: 2

The Plasma Membrane Ca2+-ATPase, a Molecular Target for Tau-induced Cytosolic Calcium Dysregulation
María Berrocal, Ana M. Mata
Neuroscience (2022) Vol. 518, pp. 112-118
Open Access | Times Cited: 8

The emerging role of mixed lineage kinase 3 (MLK3) and its potential as a target for neurodegenerative diseases therapies
Ricardo Alberto Moreno, Javier Bueno, Santiago Barber, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115511-115511
Open Access | Times Cited: 4

Disease phenotypic screening in neuron-glia cocultures identifies blockers of inflammatory neurodegeneration
Timothy J. Y. Birkle, Henriëtte M. G. Willems, John Skidmore, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109454-109454
Open Access | Times Cited: 1

Potential Alzheimer’s disease drug targets identified through microglial biology research
Izabela Lepiarz‐Raba, Taufik Hidayat, Anthony J. Hannan, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 587-602
Closed Access | Times Cited: 1

Page 1

Scroll to top